Eulerpool Terminal
The edge that pays for itself.
Current Cartesian Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
36.28 USD
+336.09 %
Median
39.78 USD
+378.13 %
Max
46.20 USD
Min
16.16 USD
Last Price
8.32 USD
Buy
12
Hold
3
Sell
0
The average target price for Cartesian Therapeutics is 36.28 USD. (+336.09 % above the current price)
The median price target of Cartesian Therapeutics is 39.78 USD.
Stock analysts from many renowned investment banks are closely examining the Cartesian Therapeutics stock. They conclude their professional Cartesian Therapeutics stock analyses with a clear recommendation for the Cartesian Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 12 | 3 | 0 | 36.28 USD |
| 2026-01-01 | 12 | 3 | 0 | 36.28 USD |
| 2025-12-01 | 12 | 3 | 0 | 35.99 USD |
| 2025-12-01 | 12 | 3 | 0 | 35.99 USD |
| 2025-11-01 | 12 | 3 | 0 | 37.45 USD |
| 2025-11-01 | 12 | 3 | 0 | 37.16 USD |
Cartesian Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Cartesian Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2028e | 23.00 M USD | -92.00 M USD | -3.54 USD |
| 2029e | 90.00 M USD | -73.00 M USD | -2.81 USD |
| 2030e | 225.00 M USD | -27.00 M USD | -1.04 USD |